246: Vas Narasimhan on the future of pharma, plus Moderna’s promise & a biotech presidential bid

1

Introduction

00:00 • 2min

2

Moderna's COVID-19 Vaccines

02:09 • 3min

3

Vaccines

05:04 • 2min

4

Biogen Earnings - Is Chris Veebaker Boring?

07:13 • 2min

5

Emergent Biosolutions vs Narcan Over the Counter

08:47 • 2min

6

Biogen CEO

10:36 • 2min

7

Is Vivek Ramaswami Testing the Waters?

12:10 • 3min

8

Are There Going to Be These Two Competing Anti-Wake Presidential Candidates Out There?

14:52 • 2min

9

The Readout Loud Podcast - Adam Vassner-Simon

16:42 • 2min

10

The Inflation Reduction Act

19:01 • 2min

11

Do You Plan to Sue to Stop the IRA?

20:35 • 2min

12

The Nine Year Provision Is Having an Impact on Drug Development Decisions

22:11 • 2min

13

Healthcare - Are We Going to Be Pure Play Innovative Medicines?

23:52 • 2min

14

Biotech - What's the Challenge in M&A?

25:28 • 2min

15

Is It Hard to Find Interesting Assets?

27:37 • 2min

16

Novartis Gene Therapy - What's Ronnie Gao Doing?

29:34 • 2min

17

Gene Therapy

31:27 • 2min

18

CAR-T Cell Therapy - What's the Outlook?

33:50 • 3min

19

What's Your Go-to Cambridge Restaurant?

36:27 • 2min

20

What Do You Think of the Readout Lab?

38:06 • 2min